Overview
Comparison of Two Doses of Intranasal Dexmedetomidine as Premedication in Children
Status:
Completed
Completed
Trial end date:
2010-08-01
2010-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Intranasal dexmedetomidine has shown to be an effective sedative when used prior to anaesthetic induction as premedication. 1mcg/kg intranasal dexmedetomidine was used in previous study and it produced satisfactory sedation in more than 50% of the children at the time of anaesthetic induction with no adverse effect. In this study we aim to compare 1mcg/kg with 2mcg/kg intranasal dexmedetomidine in children. We expect more children would attain satisfactory sedation prior to anaesthetic induction when higher dose is used.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
The University of Hong KongTreatments:
Dexmedetomidine
Criteria
Inclusion Criteria:- Age 1-12 years old
- American Society of Anesthesiologists (ASA) 1-2
- Elective surgery
- Children with autism or pervasive personality disorder
Exclusion Criteria:
- American Society of Anaesthesiologists (ASA) 3-5
- Allergy or hypersensitive reaction to dexmedetomidine
- Known cardiac arrhythmia or congenital heart disease
- Mentally disabled